Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy

BACKGROUND: Surgical resection followed by chemo-radiation postpones glioblastoma (GBM) progression and extends patient survival, but these tumours eventually recur. Multimodal treatment plans combining intraoperative techniques that maximise tumour excision with therapies aiming to remodel the immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mączyńska, Justyna, Raes, Florian, Da Pieve, Chiara, Turnock, Stephen, Boult, Jessica K. R., Hoebart, Julia, Niedbala, Marcin, Robinson, Simon P., Harrington, Kevin J., Kaspera, Wojciech, Kramer-Marek, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780306/
https://www.ncbi.nlm.nih.gov/pubmed/35057796
http://dx.doi.org/10.1186/s12916-021-02213-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780306/
https://www.ncbi.nlm.nih.gov/pubmed/35057796
http://dx.doi.org/10.1186/s12916-021-02213-z

Ejemplares similares